Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain Tissue.
Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain Tissue.
复制标题
DOI:
10.1177/0883073820987742
复制
发表时间:
2021-11
影响因子:
1.9
通讯作者:
SSADH Deficiency Investigators Consortium (SDIC)
中科院分区:
文献类型:
--
作者:
Walters DC;Lawrence R;Kirby T;Ahrendsen JT;Anderson MP;Roullet JB;Murphy EJ;Gibson KM;SSADH Deficiency Investigators Consortium (SDIC)
We have extended previous metabolic measures in post-mortem tissues (frontal and parietal lobes, pons, cerebellum, hippocampus, and cerebral cortex) obtained from a 37 y.o. male patient with succinic semialdehyde dehydrogenase deficiency (SSADHD) who expired from SUDEP (sudden unexplained death in epilepsy). Histopathological characterization of fixed cortex and hippocampus revealed mild to moderate astrogliosis, especially in white matter. Analysis of total phospholipid mass in all sections of the patient revealed a 61% increase in cortex and 51% decrease in hippocampus as compared to (n=2–4) approximately age-matched controls. Examination of mass and molar composition of major phospholipid classes showed decreases in phospholipids enriched in myelin, such as phosphatidylserine, sphingomyelin, and ethanolamine plasmalogen. Evaluation of gene expression (RT2 Profiler PCR Arrays, GABA, glutamate; Qiagen) revealed dysregulation in 14/15 GABAA receptor subunits in cerebellum, parietal, and frontal lobes with the most significant down-regulation in ε, θ, ρ1 and ρ2 subunits (7.7–9.9-fold). GABAB receptor subunits were largely unaffected, as were ionotropic glutamate receptors. The metabotropic glutamate receptor 6 was consistently down-regulated (maximum 5.9-fold) as was the neurotransmitter transporter (GABA), member 13 (maximum 7.3-fold). For other genes, consistent dysregulation was seen for interleukin 1β (maximum down-regulation 9.9-fold) and synuclein α (maximal up-regulation 6.5-fold). Our data provide unique insight into SSADHD brain function, confirming astrogliosis and lipid abnormalities previously observed in the null mouse model while highlighting long-term effects on GABAergic/glutamatergic gene expression in this disorder.
登录
查看更多内容
影响因子:
3.3
作者:
Ahrendsen, Jared T.;Anderson, Kevin R.;Anderson, Matthew P.
通讯作者:
Anderson, Matthew P.
影响因子:
3.3
作者:
Police, Anitha;Shankar, Vijay Kumar;Murthy, S. Narasimha
通讯作者:
Murthy, S. Narasimha
影响因子:
1.9
作者:
MURPHY, EJ;STEPHENS, R;HORROCKS, LA
通讯作者:
HORROCKS, LA
影响因子:
30.8
作者:
Hogema, BM;Gupta, M;Gibson, KM
通讯作者:
Gibson, KM
DOI:
10.1007/8904_2015_524
发表时间:
2016-01-01
期刊:
JIMD REPORTS, VOL 30
影响因子:
--
作者:
Schreiber, John M.;Pearl, Phillip L.;Theodore, William H.
通讯作者:
Theodore, William H.